Compile Data Set for Download or QSAR
Report error Found 13 Enz. Inhib. hit(s) with all data for entry = 3037
TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389153BDBM389153(US9951026, 3-1)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389142BDBM389142(US9951026, 1-7)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389163BDBM389163(US9951026, 3-4)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389135BDBM389135(US9951026, 1-2)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 50187691BDBM50187691(CHEMBL3828178 | US9951026, 1-1)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389141BDBM389141(US9951026, 1-6)
Affinity DataIC50: 500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389164BDBM389164(US9951026, 5-1)
Affinity DataIC50: 1.00E+4nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389140BDBM389140(US9951026, 1-5)
Affinity DataIC50: 1.00E+4nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389159BDBM389159(US9951026, 3-2)
Affinity DataIC50: 5.03E+4nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389143BDBM389143(US9951026, 1-8)
Affinity DataIC50: 5.03E+4nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389160BDBM389160(US9951026, 3-3)
Affinity DataIC50: 5.03E+4nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389139BDBM389139(US9951026, 1-4)
Affinity DataIC50: 5.03E+4nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Pharmakea

US Patent
LigandChemical structure of BindingDB Monomer ID 389138BDBM389138(US9951026, 1-3)
Affinity DataIC50: 5.03E+4nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/16/2020
Entry Details
US Patent